| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,511 |
9,033 |
$1.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,725 |
5,327 |
$828K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,955 |
4,467 |
$696K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,653 |
3,358 |
$206K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,676 |
4,541 |
$94K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,650 |
12,477 |
$85K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,569 |
3,284 |
$67K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,868 |
4,753 |
$61K |
| 80053 |
Comprehensive metabolic panel |
12,427 |
11,039 |
$59K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,694 |
1,561 |
$55K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,975 |
1,793 |
$45K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
685 |
631 |
$42K |
| 87430 |
|
3,318 |
3,172 |
$42K |
| 71045 |
Radiologic examination, chest; single view |
2,990 |
2,672 |
$39K |
| 84484 |
|
4,186 |
2,360 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,429 |
2,175 |
$36K |
| 83735 |
|
8,834 |
5,719 |
$32K |
| 83880 |
|
2,019 |
1,641 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
646 |
574 |
$30K |
| G0378 |
Hospital observation service, per hour |
217 |
180 |
$28K |
| 36415 |
Collection of venous blood by venipuncture |
11,447 |
8,152 |
$21K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
168 |
163 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,581 |
1,294 |
$21K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
298 |
275 |
$20K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,343 |
1,228 |
$19K |
| 94664 |
|
811 |
451 |
$17K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
268 |
258 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
850 |
791 |
$15K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
539 |
133 |
$13K |
| 85379 |
|
1,915 |
1,606 |
$12K |
| 83874 |
|
1,108 |
805 |
$8K |
| 82553 |
|
1,901 |
1,249 |
$8K |
| 82550 |
|
1,940 |
1,252 |
$7K |
| 83690 |
|
1,169 |
1,064 |
$7K |
| 82150 |
|
1,114 |
1,023 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,106 |
993 |
$6K |
| 81001 |
|
3,667 |
3,310 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,846 |
908 |
$5K |
| 84703 |
|
461 |
438 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
222 |
198 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,438 |
1,856 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
13 |
$3K |
| 83605 |
|
528 |
388 |
$3K |
| 80061 |
Lipid panel |
589 |
517 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
814 |
727 |
$2K |
| 84439 |
|
906 |
809 |
$2K |
| 87040 |
|
333 |
235 |
$2K |
| 82607 |
|
401 |
342 |
$2K |
| 82746 |
|
351 |
294 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
61 |
26 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
112 |
99 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
59 |
55 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
426 |
254 |
$1K |
| 87420 |
|
83 |
80 |
$1K |
| 97161 |
|
26 |
24 |
$944.85 |
| 85610 |
|
315 |
242 |
$653.89 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
53 |
13 |
$611.39 |
| 96376 |
|
84 |
40 |
$525.70 |
| 86328 |
|
19 |
17 |
$407.07 |
| 84145 |
|
21 |
14 |
$397.42 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
43 |
42 |
$392.35 |
| 94760 |
|
246 |
93 |
$370.81 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
74 |
64 |
$330.22 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
404 |
212 |
$312.10 |
| 84100 |
|
208 |
165 |
$283.18 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
331 |
253 |
$273.62 |
| 81003 |
|
187 |
178 |
$265.50 |
| 85730 |
|
70 |
64 |
$240.81 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
101 |
89 |
$236.30 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
256 |
196 |
$202.53 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
48 |
13 |
$173.79 |
| 81025 |
|
17 |
15 |
$154.84 |
| 94060 |
|
14 |
12 |
$102.12 |
| 94729 |
|
14 |
12 |
$98.89 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
17 |
12 |
$70.24 |
| 84480 |
|
14 |
14 |
$70.16 |
| 82728 |
|
14 |
14 |
$50.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
25 |
24 |
$46.43 |
| 83550 |
|
15 |
15 |
$37.87 |
| 83540 |
|
15 |
15 |
$28.07 |